Albany, CA, United States of America

Sansan Lin


Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Emeryville, CA (US) (2009)
  • Albany, CA (US) (2011)

Company Filing History:


Years Active: 2009-2011

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Sansan Lin

Introduction

Sansan Lin is an accomplished inventor based in Albany, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative solutions for hepatitis C virus (HCV) detection and treatment. With a total of 2 patents, Lin's work is recognized for its potential impact on medical diagnostics and therapeutics.

Latest Patents

Lin's latest patents include groundbreaking advancements in HCV research. The first patent focuses on "HCV multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof." This innovation describes modified HCV multiple epitope fusion antigens (MEFAs) that inhibit proteolytic cleavage by the HCV NS3 protease. The patent also details HCV immunoassays that incorporate these modified MEFAs. The second patent, titled "HCV non-structural protein mutants and uses thereof," presents modified HCV non-structural proteins. These proteins include altered NS3 domains that inhibit the proteolytic activity of the NS3 molecule while retaining conformational epitopes. This patent also discusses HCV immunoassays that utilize the modified NS3 molecules.

Career Highlights

Sansan Lin is currently employed at Novartis Vaccines & Diagnostics GmbH, where he continues to advance his research in the field of virology. His work at Novartis has allowed him to collaborate with leading experts and contribute to the development of innovative diagnostic tools.

Collaborations

Lin has worked alongside notable colleagues, including David Y Chien and Doris Guenzi Coit. These collaborations have fostered a dynamic research environment, enhancing the potential for groundbreaking discoveries in the field of HCV.

Conclusion

Sansan Lin's contributions to HCV research through his patents and work at Novartis Vaccines & Diagnostics GmbH highlight his role as a key innovator in biotechnology. His advancements in immunoassays and protein modifications are paving the way for improved diagnostic and therapeutic options for hepatitis C.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…